1. Home
  2. DNLI vs LMND Comparison

DNLI vs LMND Comparison

Compare DNLI & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • LMND
  • Stock Information
  • Founded
  • DNLI 2013
  • LMND 2015
  • Country
  • DNLI United States
  • LMND United States
  • Employees
  • DNLI N/A
  • LMND N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • LMND Property-Casualty Insurers
  • Sector
  • DNLI Health Care
  • LMND Finance
  • Exchange
  • DNLI Nasdaq
  • LMND Nasdaq
  • Market Cap
  • DNLI 1.9B
  • LMND 2.1B
  • IPO Year
  • DNLI 2017
  • LMND 2020
  • Fundamental
  • Price
  • DNLI $13.21
  • LMND $35.01
  • Analyst Decision
  • DNLI Strong Buy
  • LMND Hold
  • Analyst Count
  • DNLI 15
  • LMND 9
  • Target Price
  • DNLI $33.85
  • LMND $34.56
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • LMND 2.0M
  • Earning Date
  • DNLI 05-06-2025
  • LMND 05-06-2025
  • Dividend Yield
  • DNLI N/A
  • LMND N/A
  • EPS Growth
  • DNLI N/A
  • LMND N/A
  • EPS
  • DNLI N/A
  • LMND N/A
  • Revenue
  • DNLI N/A
  • LMND $558,600,000.00
  • Revenue This Year
  • DNLI N/A
  • LMND $29.18
  • Revenue Next Year
  • DNLI $256.73
  • LMND $31.15
  • P/E Ratio
  • DNLI N/A
  • LMND N/A
  • Revenue Growth
  • DNLI N/A
  • LMND 23.12
  • 52 Week Low
  • DNLI $10.57
  • LMND $14.03
  • 52 Week High
  • DNLI $33.33
  • LMND $53.85
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 44.46
  • LMND 58.03
  • Support Level
  • DNLI $12.86
  • LMND $31.60
  • Resistance Level
  • DNLI $13.77
  • LMND $34.19
  • Average True Range (ATR)
  • DNLI 0.72
  • LMND 1.72
  • MACD
  • DNLI -0.08
  • LMND 0.20
  • Stochastic Oscillator
  • DNLI 32.29
  • LMND 81.60

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

Share on Social Networks: